Proof of Concept for Personalized Medicine | GenomeWeb

Tech Review reports on a new study from the Journal of Clinical Oncology that provides a link between personalized medicine and better health outcomes. For the study, oncologist Lecia Sequist genetically screened patients' lung cancers and then administered a drug tailored for that type of tumor — and those patients did better than the average chemotherapy outcomes. In particular, the study looked at AstraZeneca's Iressa, an EGFR inhibitor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.